| | AIMed | BioInfer | HPRD50 | IEPA | LLL |
---|
|
size
| 1955 | 1100 | 145 | 486 | 77 |
Entity |
scope
| human P/G | P/G/R and related | human P/G | Chemicals | P/G |
coverage
| all occurrences | all occurrences | NER system | list of 16 names | list of 116 names | |
types
| no | 111 types (ontology) | no | no | P/G | |
PPI |
types
| no | 68 types (ontology) | no | no | 3 types |
binding
| no | yes | no | yes | no | |
directed
| no | yes | no | yes | yes | |
complex
| no | yes | no | no | no | |
negative
| no | yes | no | no | no | |
certainty
| no | no | yes | no | no | |
- Legend:
- Size: Number of sentences in the corpus
- Entity scope: Types of the named entities identified in the corpus: (P)rotein, (G)ene, (R)NA
- Entity coverage: Coverage of in-scope entity occurrences in each sentence
- Entity types: Explicit identification of the type of the annotated named entity occurrences
- PPI types: Explicit indication of the type of the annotated interactions
- PPI binding: Identification of the specific text spans that entail the annotated interactions
- PPI directed: Specification of the directionality of the interaction (typically identification of agent vs. patient roles)
- PPI complex: Annotation includes nested or n-ary (for n > 2) interactions
- PPI negative: Annotation of negative interactions
- PPI certainty: Annotation of the levels of certainty, or speculativeness, of interactions